Biocept, Inc. Recorded Big Gain

Thu, Jun 18, 2020 at 05:30 PM

Biocept, Inc. (BIOC:NASDAQ) shot up at $0.95, a gain of 47.2%. The stock got featured on our News Catalysts scanner on Fri 29 May 20 at 09:43 AM in the 'BIOTECH' category. From Wed 03 Jun 20, the stock recorded 50.00% Up Days and 63.64% Green Days

The stock spiked on Fri 28 Feb 20 at $0.79 with a volume of 88M+.

About Biocept, Inc. (BIOC:NASDAQ)

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample.

Top 10 Gainers:

Alpine Immune Sciences, Inc. (ALPN:NASDAQ), 124.85%
Urban One, Inc. (UONE:NASDAQ), 96.7%
Aethlon Medical, Inc. (AEMD:NASDAQ), 89.36%
Neonode Inc. (NEON:NASDAQ), 69.02%
Farmmi, Inc. (FAMI:NASDAQ), 58.38%
Nuverra Environmental Solutions, Inc. (NES:NYSEMKT), 53.68%
Carver Bancorp, Inc. (CARV:NASDAQ), 48.99%
HUSN (HUSN:NASDAQ), 48.43%
Biocept, Inc. (BIOC:NASDAQ), 47.2%
China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 41.16%